Violeta Moniaki

539 total citations
21 papers, 360 citations indexed

About

Violeta Moniaki is a scholar working on Physiology, Endocrine and Autonomic Systems and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Violeta Moniaki has authored 21 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 11 papers in Endocrine and Autonomic Systems and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Violeta Moniaki's work include Obstructive Sleep Apnea Research (17 papers), Neuroscience of respiration and sleep (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Violeta Moniaki is often cited by papers focused on Obstructive Sleep Apnea Research (17 papers), Neuroscience of respiration and sleep (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Violeta Moniaki collaborates with scholars based in Greece, Cyprus and United States. Violeta Moniaki's co-authors include Izolde Bouloukaki, Sophia E. Schiza, Charalampos Mermigkis, Νikolaos Tzanakis, Nikolaos M. Siafakas, Eleftherios M. Kallergis, Panagiotis Panagou, Ioannis D Komninos, Katerina Micheli and Frank Sofras and has published in prestigious journals such as European Respiratory Journal, Nutrients and Journal of Clinical Sleep Medicine.

In The Last Decade

Violeta Moniaki

19 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violeta Moniaki Greece 9 304 212 164 64 39 21 360
Dariusz Woźniak United Kingdom 6 328 1.1× 249 1.2× 163 1.0× 74 1.2× 69 1.8× 12 410
Elisabet Martínez-Cerón Spain 11 276 0.9× 161 0.8× 164 1.0× 64 1.0× 46 1.2× 28 385
Emilia Mazzuca Italy 9 277 0.9× 163 0.8× 115 0.7× 54 0.8× 39 1.0× 12 371
Peter R. Buchanan Australia 6 332 1.1× 247 1.2× 140 0.9× 88 1.4× 96 2.5× 11 429
Laura Vigil Spain 11 207 0.7× 118 0.6× 143 0.9× 39 0.6× 34 0.9× 29 329
Vikram Comondore Canada 8 272 0.9× 191 0.9× 147 0.9× 73 1.1× 51 1.3× 10 351
Eduardo Borsini Argentina 9 285 0.9× 224 1.1× 133 0.8× 50 0.8× 35 0.9× 58 330
Pierpaolo Baiamonte Italy 6 221 0.7× 135 0.6× 91 0.6× 44 0.7× 37 0.9× 7 266
Ron B. Mitchell United States 5 330 1.1× 249 1.2× 213 1.3× 28 0.4× 27 0.7× 6 374
Mirjam Ljunggren Sweden 10 233 0.8× 156 0.7× 116 0.7× 63 1.0× 51 1.3× 32 299

Countries citing papers authored by Violeta Moniaki

Since Specialization
Citations

This map shows the geographic impact of Violeta Moniaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Moniaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Moniaki more than expected).

Fields of papers citing papers by Violeta Moniaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Moniaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Moniaki. The network helps show where Violeta Moniaki may publish in the future.

Co-authorship network of co-authors of Violeta Moniaki

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Moniaki. A scholar is included among the top collaborators of Violeta Moniaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Moniaki. Violeta Moniaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouloukaki, Izolde, Antonios Christodoulakis, Violeta Moniaki, et al.. (2025). Association of Vitamin B12 Status with Polysomnographic Parameters and Cardiovascular Disease in Patients with Obstructive Sleep Apnoea. Nutrients. 17(19). 3079–3079.
2.
Bouloukaki, Izolde, et al.. (2025). Polysomnography Differences Between Sleepy and Non-Sleepy Obstructive Sleep Apnea (OSA) Patients. Healthcare. 13(5). 478–478. 2 indexed citations
3.
Bouloukaki, Izolde, Paschalis Steiropoulos, Nikos Tzanakis, et al.. (2024). Prevalence and Characteristics of Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: Overlap Syndrome. Life. 14(5). 547–547. 4 indexed citations
4.
Bouloukaki, Izolde, et al.. (2023). Impact of the COVID-19 pandemic on positive airway pressure adherence and patients’ perspectives in Greece: the role of telemedicine. Journal of Clinical Sleep Medicine. 19(10). 1743–1751. 3 indexed citations
6.
Bouloukaki, Izolde, et al.. (2021). Characteristics of Patients with Obstructive Sleep Apnea at High Risk for Cardiovascular Disease. Medicina. 57(11). 1265–1265. 7 indexed citations
7.
Bouloukaki, Izolde, Charalampos Mermigkis, Violeta Moniaki, et al.. (2020). Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment. Journal of Clinical Sleep Medicine. 17(3). 533–544. 25 indexed citations
8.
Bouloukaki, Izolde, et al.. (2019). Cardiovascular Effect and Symptom Profile of Obstructive Sleep Apnea: Does Sex Matter?. Journal of Clinical Sleep Medicine. 15(12). 1737–1745. 22 indexed citations
9.
10.
11.
Bouloukaki, Izolde, Charalampos Mermigkis, Νikolaos Tzanakis, et al.. (2017). Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities. Mediators of Inflammation. 2017. 1–13. 51 indexed citations
12.
Bouloukaki, Izolde, et al.. (2017). Evaluation of inflammatory markers in a large sample of Obstructive Sleep Apnea Patients. PA2319–PA2319. 4 indexed citations
13.
Bouloukaki, Izolde, Charalampos Mermigkis, Νikolaos Tzanakis, et al.. (2016). The role of compliance with PAP use on blood pressure in patients with obstructive sleep apnea: is longer use a key-factor?. Journal of Human Hypertension. 31(2). 106–115. 2 indexed citations
14.
Bouloukaki, Izolde, et al.. (2015). Tiotropium Respimat Soft Mist Inhaler versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD. Sleep And Breathing. 20(2). 605–612. 6 indexed citations
15.
Bouloukaki, Izolde, et al.. (2014). Tiotropium respimat versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD. European Respiratory Journal. 44(Suppl 58). P3280–P3280. 1 indexed citations
16.
Bouloukaki, Izolde, Charalampos Mermigkis, Νikolaos Tzanakis, et al.. (2014). Intensiveversusstandard follow-up to improve continuous positive airway pressure compliance. European Respiratory Journal. 44(5). 1262–1274. 67 indexed citations
17.
Bouloukaki, Izolde, Frank Sofras, Charalampos Mermigkis, et al.. (2014). Abnormal Cytokine Profile in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome and Erectile Dysfunction. Mediators of Inflammation. 2014. 1–7. 30 indexed citations
18.
Bouloukaki, Izolde, Ioannis D Komninos, Charalampos Mermigkis, et al.. (2013). Translation and validation of Berlin questionnaire in primary health care in Greece. BMC Pulmonary Medicine. 13(1). 6–6. 47 indexed citations
19.
Bouloukaki, Izolde, Fotis Kapsimalis, Charalampos Mermigkis, et al.. (2010). Prediction of obstructive sleep apnea syndrome in a large Greek population. Sleep And Breathing. 15(4). 657–664. 39 indexed citations
20.
Schiza, Sophia E., Izolde Bouloukaki, Charalampos Mermigkis, et al.. (2010). Utility of formulas predicting the optimal nasal continuous positive airway pressure in a Greek population. Sleep And Breathing. 15(3). 417–423. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026